Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Methylprednisolone administration resulted in marked deterioration of bone quality, with significant reductions in 25(OH)D3, IGF-1, and increased osteocalcin, TNF-α, IL-1β, HSP-27, RANK, and RANKL expression, accompanied by severe trabecular bone loss, all treatment groups showed notable recovery, with the most pronounced restoration in teriparatide and high-dose hydroxybenzoic acid groups.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Animal research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Sixty-eight male Swiss Albino mice were randomly assigned to seven groups: Healthy Control, Osteoporosis (methylprednisolone 10 mg/kg), Teriparatide (3 μg/kg), Low-Dose Lentinan (200 mg/kg), High-Dose Lentinan (400 mg/kg), Low-Dose HBA (50 μg/kg), and High-Dose HBA (100 μg/kg).

Source: Abstract.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Therapeutic potential of hydroxybenzoic acid and lentinan in mitigating glucocorticoid-induced osteoporosis: an experimental study

Study design awaiting verification · Frontiers in Pharmacology · 2026

Original publication title

Therapeutic potential of hydroxybenzoic acid and lentinan in mitigating glucocorticoid-induced osteoporosis: an experimental study

Busra Soyler; Tugba Melike Parlak; Ibrahim Buyuktaskapulu; Muhammed Demircioglu; Muhammet Bahaeddin Dortbudak; Ali Kocyigit; Ismail Demircioglu; Annalisa Chiavaroli; Burak Dik

Copyright © 2026 Soyler, Parlak, Buyuktaskapulu, Demircioglu, Dortbudak, Kocyigit, Demircioglu, Chiavaroli and Dik.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: What background does the paper provide?

The present study aimed to elucidate the therapeutic efficacy and mechanistic roles of Hydroxybenzoic Acid and Lentinan in counteracting glucocorticoid-induced osteoporosis (GIOP) in mice, with a focus on bone metabolism, inflammation, and oxidative stress pathways.

Source: Introduction

Abstract: What methods does the paper describe?

Sixty-eight male Swiss Albino mice were randomly assigned to seven groups: Healthy Control, Osteoporosis (methylprednisolone 10 mg/kg), Teriparatide (3 μg/kg), Low-Dose Lentinan (200 mg/kg), High-Dose Lentinan (400 mg/kg), Low-Dose HBA (50 μg/kg), and High-Dose HBA (100 μg/kg). In the study, all treatments were administered daily for a duration of 10 weeks.

Source: Methods

Abstract: Results and Discussion

Methylprednisolone administration resulted in marked deterioration of bone quality, with significant reductions in 25(OH)D3, IGF-1, and increased osteocalcin, TNF-α, IL-1β, HSP-27, RANK, and RANKL expression, accompanied by severe trabecular bone loss, all treatment groups showed notable recovery, with the most pronounced restoration in teriparatide and high-dose hydroxybenzoic acid groups. Mechanistically, hydroxybenzoic acid exerted potent anti-osteoclastic effects through RANK/RANKL pathway suppression, while Lentinan enhanced osteoblastic activity and mitigated inflammatory damage. In conclusion, these results provide preclinical evidence that HBA and lentinan warrant further investigation as potential adjuncts to established anti-osteoporotic therapy in the setting of long-term glucocorticoid use.

Source: Results and Discussion
Authors’ abstract

Introduction

The present study aimed to elucidate the therapeutic efficacy and mechanistic roles of Hydroxybenzoic Acid and Lentinan in counteracting glucocorticoid-induced osteoporosis (GIOP) in mice, with a focus on bone metabolism, inflammation, and oxidative stress pathways.

Methods

Sixty-eight male Swiss Albino mice were randomly assigned to seven groups: Healthy Control, Osteoporosis (methylprednisolone 10 mg/kg), Teriparatide (3 μg/kg), Low-Dose Lentinan (200 mg/kg), High-Dose Lentinan (400 mg/kg), Low-Dose HBA (50 μg/kg), and High-Dose HBA (100 μg/kg). In the study, all treatments were administered daily for a duration of 10 weeks.

Results and Discussion

Methylprednisolone administration resulted in marked deterioration of bone quality, with significant reductions in 25(OH)D3, IGF-1, and increased osteocalcin, TNF-α, IL-1β, HSP-27, RANK, and RANKL expression, accompanied by severe trabecular bone loss, all treatment groups showed notable recovery, with the most pronounced restoration in teriparatide and high-dose hydroxybenzoic acid groups. Mechanistically, hydroxybenzoic acid exerted potent anti-osteoclastic effects through RANK/RANKL pathway suppression, while Lentinan enhanced osteoblastic activity and mitigated inflammatory damage. In conclusion, these results provide preclinical evidence that HBA and lentinan warrant further investigation as potential adjuncts to established anti-osteoporotic therapy in the setting of long-term glucocorticoid use.

Publication and source details

Original title: Therapeutic potential of hydroxybenzoic acid and lentinan in mitigating glucocorticoid-induced osteoporosis: an experimental study

Busra Soyler; Tugba Melike Parlak; Ibrahim Buyuktaskapulu; Muhammed Demircioglu; Muhammet Bahaeddin Dortbudak; Ali Kocyigit; Ismail Demircioglu; Annalisa Chiavaroli; Burak Dik

Frontiers in Pharmacology · 2026

* Correspondence: Annalisa Chiavaroli, annalisa.chiavaroli@unich.it
†

ORCID: Busra Soyler, orcid.org/0009-0006-9648-7029; Tugba Melike Parlak, orcid.org/0000-0003-3277-0336; Ibrahim Buyuktaskapulu, orcid.org/0009-0004-9484-3486; Muhammed Demircioglu, orcid.org/0000-0001-8082-8630; Muhammet Bahaeddin Dortbudak, orcid.org/0000-0001-5777-964X; Ali Kocyigit, orcid.org/0000-0002-9354-7480; Ismail Demircioglu, orcid.org/0000-0002-0724-3019; Annalisa Chiavaroli, orcid.org/0000-0002-3399-967X; Burak Dik, orcid.org/0000-0003-2738-6911

Copyright © 2026 Soyler, Parlak, Buyuktaskapulu, Demircioglu, Dortbudak, Kocyigit, Demircioglu, Chiavaroli and Dik.2026Soyler, Parlak, Buyuktaskapulu, Demircioglu, Dortbudak, Kocyigit, Demircioglu, Chiavaroli and Dikhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This study was supported by Selcuk University Scientific Research Projects (Project number: 24401115).

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T23:13:19.563499+00:00

DOI: 10.3389/fphar.2026.1957515 · PMC13745373